Medications

Novartis profit slips as key drug goes generic

Swiss drug company Novartis saw net profit slip in the third quarter as the loss of a key drug to generic use in the United States outweighed strong sales of its psoriasis drug Cosentyx and MS treatment Gilenya.

Medications

Lawmakers demand answers on leukemia drug price hikes

Two top lawmakers on Thursday demanded information from a drug company that has raised prices on a leukemia drug, calling increases of tens of thousands of dollars a sign the company puts profits before patients.

Oncology & Cancer

Combination therapy shows promise for chronic myeloid leukemia

A study in mice combining two inhibitor drugs for treatment of chronic myeloid leukemia (CML) has revealed potential for not only stopping the disease completely, but also significantly lowering the cost for treatment. CML ...

Oncology & Cancer

Body's own gene editing system generates leukemia stem cells

Cancer stem cells are like zombies—even after a tumor is destroyed, they can keep coming back. These cells have an unlimited capacity to regenerate themselves, making more cancer stem cells and more tumors. Researchers ...

Diabetes

New hope for a type 2 diabetes cure

The cancer treatment drug Imatinib, otherwise known as Gleevec is approved to treat various forms of cancer, mostly notably chronic myeloid leukemia (CML). However, researchers have stumbled onto another possible use for ...

Oncology & Cancer

Excess relative risk of repeat CT scans can be quantified

(HealthDay)—Excess relative risk of computed tomography (CT) scans for quantification of cystic fibrosis (CF) can be calculated, according to a letter published in the Dec. 1 issue of the American Journal of Respiratory ...

page 5 from 10